Missouri SB1156 establishes insurance coverage rules for prescription insulin drugs, including cost-sharing limits and rebate confidentiality.
Missouri SB1156 enacts provisions to regulate insurance coverage for prescription insulin drugs. It prohibits health carriers from disclosing rebate information as a trade secret and limits cost-sharing for enrollees to no more than $30 per 30-day supply. The bill also mandates that cost-sharing calculations for insulin drugs include all rebates received. These provisions apply to health benefit plans delivered, issued for delivery, continued, or renewed on or after January 1, 2027.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.